Below you will find a link to a valuable new review article on ongoing changes in the opportunities for evaluation and management of men with both hormone-sensitive and castration-resistant, metastatic prostate cancer (mHSPC and mCRPC).
This new article by Aggarwal et al. (“Emerging categories of disease in advanced prostate cancer and their therapeutic implications“) is probably a very valuable resource for patients with newly diagnosed and/or progressive forms of metastatic prostate cancer, as well as for support group leaders and other prostate cancer educators.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistnt, hormon-sensitive, metastatic, Treatment, type |
THE "NEW" PROSTATE CANCER INFOLINK 
I bet it’s 3 to 5 years since either Aggarwal or Small prescribed ketoconazole to a patient before abiraterone or enzalutamide.